This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Zein Obagi Debuts Launch Of New Physician Skincare Line At The American Academy Of Dermatology Annual Meeting





IRVINE, Calif., March 16, 2012 /PRNewswire/ --  ZO® Skin Health By Zein Obagi, M.D. is pleased to announce the global launch of a new comprehensive medical skincare line, ZO® Medical, at the American Academy of Dermatology Annual Meeting.

To kick off this important launch, ZO® Skin Health experts will be on hand in Booth #4207 to give demonstrations of the 11 products in the range which will be sold exclusively in leading physician practices throughout the US and Canada. Created by Zein Obagi, M.D., the science behind ZO® Medical represents Dr. Obagi's proven way of thinking about and caring for skin by repairing it at the cellular level.  The products were developed to work synergistically from the inside out, activating and stimulating skin's cells to nourish, repair and maintain healthy skin.

The new line centers around Dr. Obagi's ZO® philosophy of the Skin Health Circle™ which uses ZO® Medical solutions to address a wide range of applications—therapeutic, maintenance, daily skin care, and protection. ZO® Medical utilizes the most potent ingredients in high concentrations, pure retinol, advanced peptides, and powerful antioxidants.

"ZO® Medical will raise the bar on skin health, providing topical solutions with advanced levels of tested, potent, proven ingredients," states Dr. Obagi.  "This line is the culmination of decades of learnings and outcomes with a unique proven approach to skincare. I am very excited to unveil ZO® Medical at the AAD Annual Meeting to my colleagues and partners in Dermatology."

ZO® Medical consists of 11 star-quality products, priced from $35 - $400, featuring breakthrough delivery systems and advanced technologies, all of which will be revealed for the first time at AAD. The line includes novel formulations targeting pigmentation and discoloration, acne and oily skin, visible signs of skin aging, redness and rosacea, and potent UV protection. Please join Dr. Obagi at booth #4207 on March 17th at 1pm and again on March 18th at 1 pm for a brief presentation.

To learn more, watch the new premier video featuring Dr. Obagi and sign up for updates at www.zopremiere.com.

To schedule an interview with Dr. Zein Obagi, or to receive more information about ZO® Skin Health and ZO® Medical – Melissa Kelz, melissakelz@kelzpr.com or Patty Mathews, pattymathews@kelzpr.com

About Dr. Obagi: Dr. Zein Obagi, MD, practices at the Obagi Skin Health Institute in Beverly Hills and the Obagi Skin Health Institute in San Gabriel, California, plus in more than 16 countries around the world.

Dr. Zein Obagi is not affiliated with Obagi® Medical Products, Inc. in any business capacity. Likewise, Obagi® Medical Products does not sell any ZO® Skin Health or ZO® Medical product or endorse the views expressed by ZO® or Dr. Obagi as they relate to the use of Obagi Nu-Derm® or other Obagi® Medical products, or any other topics.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs